| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 9, 2024 | Atlas Venture scores another $450m fundraise to continue strong capital raising pace |
Early-stage venture capital investor Atlas Venture has hit a $450m final close for its oversubscribed fourteenth fundrai
|
| Dec 5, 2024 | Atlas Venture closes on $450m for oversubscribed 14th fund | |
| Oct 1, 2021 | Atlas Venture Closes $300M Second Opportunity Fund | Atlas Venture, a Cambridge, Mass.-based early stage venture capital and venture creation firm investing in biotech innovation, closed its second Opportunity Fund, at $300m.
Led by David Grayzel, Kevin Bitterman, Bruce Booth, Jean-François F... |
| Jun 7, 2020 | Atlas Venture Raises $400 Million For Fund XII | Leading early-stage venture capital firm Atlas Venture announced that it closed its twelfth fund at $400 million
Leading early-stage venture capital firm Atlas Venture announced that it closed its twelfth fund at $400 million as part of a h... |
| Jun 5, 2020 | Atlas Venture Announces $400 Million Fund XII | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly oversubscribed fu... |
| Jun 5, 2020 | Atlas Venture : Announces $400 Million Fund XII and Expansion of Partnership | Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly oversubscribed fundraise. With the closing of Fund X... |
| Jan 2, 2019 | Atlas Venture raises $250M for later-stage investments
W h i t e p a p e r
Vital Precision for Cost Reduction, QA, and Regulatory Compliance | Atlas Venture has raised $250 million to invest in existing portfolio companies. The fund, the first of its kind operated by Atlas, will enable the VC shop to support its startups through series B and beyond.
Sponsored by Agilent Technologi... |
| Jan 2, 2019 | Atlas Venture raises $250M for Opportunity Fund | The total amount raised represents a 25 percent increase over the $200 million that Atlas set out to raise when it opened the fund a little more than a month ago, according to a Nov. 29 Securities and Exchange Commission filing.
Unum Therap... |
| Jan 2, 2019 | Atlas Venture closes inaugural opportunity fund on $250m | Biotech VC firm Atlas Venture has raised $250m for the final close of its first opportunity fund. Atlas will tap the o |
| Jan 2, 2019 | Atlas Venture raises $250M for later-stage investments | Atlas Venture has raised $250 million to invest in existing portfolio companies. The fund, the first of its kind operated by Atlas, will enable the VC shop to support its startups through series B and beyond.
Massachusetts-based Atlas made ... |
| Jun 29, 2017 | Atlas Venture Announces $350 Million Fund XI | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its eleventh fund, raising $350 million in a highly oversubscribed f... |
| Dec 18, 2015 | Daily funding roundup - December 18, 2015 | Pave secured $300M; Navitor Pharmaceuticals, Inc received $33M; Checkpoint Surgical raised $7.5M
Jolla Ltd., a Finnish mobile company and developer of open mobile operating system Sailfish OS, today announced that it has closed its C invest... |
| Nov 10, 2015 | Daily funding roundup - November 10, 2015
Early-Stage Venture-Capital Investors
Early-Stage Venture-Capital Investors | Careem secured $60M; Transfix raised $12M; Spiro closed $1.5M
Trucking remains the most widely used way of shipping goods, with heavy duty semi-trucks being responsible for shipping 70% of all U.S. freight.. But it's also an industry that h... |
| Oct 7, 2015 | Daily funding roundup - October 7, 2015 | AppDirect raised $140M; CampoRico Fertilizers secured $40M; OptiNose nabbed $30M
TNI medical AG, a Würzburg, Germany-based medical device company, raised €3 million ($3.36 million) in venture capital funding. Pathena Fund made the investmen... |
| Oct 6, 2015 | Rodin Therapeutics Appoints Adam J. Rosenberg as CEO | The Board of Directors of Rodin Therapeutics, a Cambridge, MA-based biotechnology company applying insights from epigenetics to develop novel therapeutics for neurological disorders, has appointed Adam J. Rosenberg as Chief Executive Office... |
| Apr 17, 2015 | Now 'Unshackled,' Atlas Venture Raises $280M for Biotech Deals | You might have recently caught wind of FKA, a Cambridge venture capital firm, whose letters stands for “Formerly Known as Atlas.” The firm includes the group of technology VCs that previously had been part of Atlas Venture until the firm sp... |
| Apr 17, 2015 | With new $280M fund, Atlas Venture cuts the IT and “right-sizes” to biotech | The new incarnation of Atlas just moved to 400 Technology Square in the life sciences-rich Kendall Park, also in Cambridge. Notably, Atlas just brought on a new chief financial officer- Ommer Chohan, former CFO of Summerhill Ventures in Tor... |
| May 2, 2013 | Atlas Venture closes ninth fund on $265m | Venture capital firm Atlas Venture has reportedly closed its ninth fund – and the first raised since reorganising R |
| Jan 29, 2009 | Atlas Venture Closes New Fund with $283M, Does the Staffing Shuffle | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Boston- and London-based Atlas Venture announced today that it has closed its eighth fund with $283 million committed by existing limited partners Kisco Management, The Kresge... |
| Atlas Venture raises $250M for Opportunity Fund | A biotechnology venture capital firm is ringing in the new year with its latest fund, having raised a quarter of $1 billion.
Cambridge, Massachusetts-based Atlas Venture said Wednesday that it closed its first Opportunity Fund, or AVOF I, w... |
| Manage your consent preferences
Now 'Unshackled,' Atlas Venture Raises $280M for Biotech Deals | |
| With new $280M fund, Atlas Venture cuts the IT and “right-sizes” to biotech | Atlas Venture just closed its tenth fund at $280 million – marking its switch over to a biotech-only firm, the firm’s Bruce Booth blogged today.
“At our core, we’re biotech therapeutics startup folks, and that’s where we’re going to focus,”... |